Wang Yichen
Private Equity Investor chez Healthcare Royalty Management LLC
Profil
Yichen Wang, M.D., Ph.D., is a Vice President at HCRx.
Dr. Wang primarily supports HCRx’s research efforts.
Dr. Wang also participates in HCRx’s business development and transaction-related activities, including financial analysis, transaction structuring and due diligence.
Prior to joining HCRx, Dr. Wang was an experienced life science strategy consultant.
Dr. Wang holds a Ph.D.
in Molecular Biology and Genetics and an M.B.A from the University of Delaware.
Dr. Wang is also a trained Ophthalmologist and obtained her M.D.
from the Capital Medical University (Beijing, China).
Postes actifs de Wang Yichen
Sociétés | Poste | Début |
---|---|---|
Healthcare Royalty Management LLC
Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Private Equity Investor | - |
Formation de Wang Yichen
University of Delaware | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Healthcare Royalty Management LLC
Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Finance |